Free Research Preview. DrugChatter may produce inaccurate information.
Ask Anything...
Profile for Cellectis S.A. (CLLS)
« Back to company indexCLLS Chatter Timeline
Stock Ticker for CLLS
Most Active Tweeters for CLLS
No tweets foundRecent Tweets for CLLS
 |
@beach_trades $CLLS wants that gap https://t.co/sL1SA4kbuq April 17th 2023, 11:04pm |
|
@beach_trades $CLLS unfound #CRISPR https://t.co/ebz67beo8D April 17th 2023, 3:04pm |
 |
@MarcJacksonLA $CLLS Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Triple… https://t.co/80kTt2zvI0 April 17th 2023, 2:04pm |
 |
@CHItraders $CLLS Reported Ealier, Cellectis Presents Preclinical Data On TALEN-Edited MUC1 CAR T-Cells To Enhance Efficacy In… https://t.co/cjzt687sQP April 17th 2023, 12:04pm |
 |
@picks_horse $CLLS Cellectis Presents Preclinical Data on TALEN(R)-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Trip… https://t.co/5YQp7q7GpG April 17th 2023, 11:04am |
|
@beach_trades $CLLS Cellectis Presents Preclinical Data on TALEN(R)-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Trip… https://t.co/FQJ7A4TwJj April 17th 2023, 10:04am |
 |
@FlashAlert_me $CLLS [15s. delayed] filed form 6-K on April 17, 06:05:07 https://t.co/5PhQc5YskA April 17th 2023, 10:04am |
 |
@biotechradar_eu Cellectis $ALCLS $CLLS Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting… https://t.co/tkXjjIDm20 April 17th 2023, 6:04am |
 |
@StckPro $CLLS NEW ARTICLE : Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Ta… https://t.co/QeU6paXIZM April 17th 2023, 6:04am |
 |
@StockNewsBot2 $CLLS Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Triple… https://t.co/ClnYuNvyxt April 17th 2023, 6:04am |
 |
@stock_titan $CLLS Cellectis Presents Preclinical Data on TALEN®-edited MUC1 CAR T-cells to Enhance Efficacy in Targeting Triple… https://t.co/GR474fn02n April 17th 2023, 6:04am |
 |
@bthefirsttoknow First out// $CLLS: Cellectis Presents Preclinical Data on TALEN-edited MUC1 CAR T-cells to Enhance Efficacy in Targ… https://t.co/MOwrzsHVp1 April 17th 2023, 6:04am |
 |
@signaljumper $CLLS #chartcheck #signaljumper #followme charting, DD and alert Data or presentation upcoming this week (list… https://t.co/1KPAXiFruq April 16th 2023, 11:04am |
|
@beach_trades $CLLS #CRSP $NTLA Fewer Unwanted Mutations – New Technique Opens the Door to Safer Gene Editing - https://t.co/onO0EwalEC April 15th 2023, 10:04pm |
|
@StockNewsBot2 $CLLS Monthly information on share capital and company voting rights https://t.co/XuQr6ODqoY April 12th 2023, 8:04pm |
|
@stock_titan $CLLS Monthly information on share capital and company voting rights https://t.co/HUCGXYrrsk #investing April 12th 2023, 8:04pm |
 |
@Beeken_health $CLLS - Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate… https://t.co/WS5RyFuOAX April 12th 2023, 10:04am |
|
@Beeken_health $CLLS - Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate… https://t.co/6CiKrAqNkY April 12th 2023, 10:04am |
 |
@Tradesense_me $CLLS ? ? Press Release Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured P… https://t.co/zeoqJe8ASS April 11th 2023, 11:04pm |
|
@biotechradar_eu Cellectis $ALCLS $CLLS Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candi… https://t.co/cBeOeyZSSW April 11th 2023, 8:04pm |
 |
@investor_feed $CLLS 6-K Cellectis (11 Apr, 4:35pm) ? Cellectis Announces Dosing of the First Patient in Europe with its In-h… https://t.co/w3wlS7klNY April 11th 2023, 8:04pm |
|
@StockNewsBot2 $CLLS Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UC… https://t.co/SRXAtE9ABG April 11th 2023, 8:04pm |
|
@stock_titan $CLLS Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UC… https://t.co/67wkfmHkj3 April 11th 2023, 8:04pm |
 |
@ChartMill $CLLS has a bad technical rating, but it does show a decent setup pattern. https://t.co/6Tnk5owFv2 https://t.co/jE8GF1orfG April 9th 2023, 9:04am |
|
@StockNewsBot2 $CLXT $CLLS Calyxt Announces Effective Date of Reverse Stock Split https://t.co/b60TCLS51A April 7th 2023, 8:04pm |
|
@stock_titan $CLXT $CLLS Calyxt Announces Effective Date of Reverse Stock Split https://t.co/8OTx9BZoWa April 7th 2023, 8:04pm |
 |
@subir389 $clls Top analyst price target for next week. ? ? ? https://t.co/pHQRUZV8BH April 7th 2023, 7:04am |
 |
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 261 April 5th 2023, 12:04pm |
 |
@AmericanBanking Cellectis $CLLS PT Lowered to $16.00 https://t.co/UbPBfW1Mzd #stocks April 5th 2023, 11:04am |
 |
@CFinancialNews Cellectis $CLLS PT Lowered to $16.00 https://t.co/0rS3qc0Bh1 #markets April 5th 2023, 11:04am |
|
@Beeken_health $CLLS - Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreem… https://t.co/4rOZQLKGLJ April 5th 2023, 9:04am |
|
@Beeken_health $CLLS - Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreem… https://t.co/CBMEtM1sam April 5th 2023, 7:04am |
|
@Beeken_health $CLLS - Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreem… https://t.co/d8hhTrTQ6D April 5th 2023, 7:04am |
|
@Beeken_health $CLLS - Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreem… https://t.co/QePCpmQLqZ April 5th 2023, 7:04am |
|
@Beeken_health $CLLS - Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreem… https://t.co/pG09Sp5xwF April 5th 2023, 7:04am |
 |
@furualerts Breaking news: $CLLS Cellectis S.A. is down 1.5% since the open today. At 4:00 PM, the stock was trading at $1.97,… https://t.co/Cat5u9u2VU April 4th 2023, 10:04pm |
 |
@Briefingcom $CLLS: Cellectis enters into warrant agreement and finalized the related ancillary documents required under the... https://t.co/qbchm1NLS2 April 4th 2023, 10:04pm |
|
@biotechradar_eu Cellectis $ALCLS $CLLS enters into warrant agreement with the European Investment Bank related to credit facility a… https://t.co/eFGa0gEeqf April 4th 2023, 8:04pm |
 |
@PennyStockNews5 $CLLS ? Sentiments: title 0.8402 | summary 0.8126 No price Data https://t.co/lB5apLtPaX April 4th 2023, 8:04pm |
|
@StockNewsBot2 $CLLS Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreemen… https://t.co/0JXw1aYWv7 April 4th 2023, 8:04pm |
|
@stock_titan $CLLS Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreemen… https://t.co/QVO5fRJkRH April 4th 2023, 8:04pm |
 |
@Juliett35612597 $clls Top analyst price target for next week. ? ? ? https://t.co/b4ELX87sWe April 3rd 2023, 9:04am |
 |
@marrybt3 $clls Top analyst price target for next week. ? ? ? https://t.co/sm6yvqRfqy April 1st 2023, 1:04pm |
 |
@Baker48524744 $clls Top analyst price target for next week. ? ? ? https://t.co/TkFUgLNj8n April 1st 2023, 2:04am |
 |
@LeahSDaly12 $clls Top analyst price target for next week. ? ? ? https://t.co/w63JmXl1nH March 31st 2023, 8:03am |
 |
@TinaBai99786460 $clls *Top analyst price target for next week ??? https://t.co/QpLTfstTLG March 29th 2023, 5:03am |
 |
@PeterHa18329727 $clls *Top analyst price target for next week ??? https://t.co/utOxlefBqA March 28th 2023, 11:03am |
 |
@Rose30963993 $clls *Top analyst price target for next week ??? https://t.co/pZPLG2wJv5 March 28th 2023, 10:03am |
|
@PeterHa18329727 $clls *Top analyst price target for next week ??? https://t.co/utOxlef3B2 March 28th 2023, 1:03am |
|
@Rose30963993 $clls *Top analyst price target for next week..??? https://t.co/XqisL2c67K March 28th 2023, 1:03am |
DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC
2004 - 2023. All rights reserved.